Equities

Know Labs Inc

Know Labs Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.2452
  • Today's Change0.005 / 2.08%
  • Shares traded174.05k
  • 1 Year change-38.68%
  • Beta1.5067
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Know Labs Inc's net income fell 8.45% from a loss of 15.29m to a larger loss of 16.58m despite flat revenues.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-277.97%
Return on equity-2,135.79%
Return on investment-1,477.22%
More ▼

Cash flow in USDView more

In 2024, cash reserves at Know Labs Inc fell by 4.91m. Cash Flow from Financing totalled 7.98m or -- of revenues. In addition the company used 12.83m for operations while cash used for investing totalled 66.35k.
Cash flow per share-0.1957
Price/Cash flow per share--
Book value per share-0.02
Tangible book value per share-0.02
More ▼

Balance sheet in USDView more

Know Labs Inc appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, this company's debt load is greater than its assets while day-to-day operations are losing money. Know Labs Inc has considerable financial risk.
Current ratio0.6025
Quick ratio--
Total debt/total equity--
Total debt/total capital1.84
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.